Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Invitae Corp
(NY:
NVTA
)
N/A
UNCHANGED
Last Price
Updated: 7:00 PM EST, Feb 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
0.0888 (12)
Ask (Size)
0.0896 (75)
Prev. Close
0.0891
Today's Range
N/A - N/A
52wk Range
0.3600 - 0.7639
Shares Outstanding
217,339,666
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal
April 25, 2024
Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sales growth. The acquisition of Invitae is expected to bolster Labcorp's...
Via
Benzinga
Softbank-Backed Cohesity To Acquire Veritas Data Security Unit For $3B: Report
February 08, 2024
Cohesity, a U.S.-based data security software company, is set to acquire the data protection business of Veritas, a subsidiary of Carlyle Group.
Via
Benzinga
Performance
More News
Read More
US Stocks Gain; Uber Posts Upbeat Sales
February 07, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The New York Stock Exchange Will Start Delisting Invitae (NVTA) Stock
February 06, 2024
Via
InvestorPlace
Why Is Agrify (AGFY) Stock Up 57% Today?
February 06, 2024
Via
InvestorPlace
Is Invitae Stock a Buy Now?
January 29, 2024
Via
The Motley Fool
Looking Into Invitae's Recent Short Interest
January 18, 2024
Via
Benzinga
(NVTA) - Analyzing Invitae's Short Interest
January 01, 2024
Via
Benzinga
NVTA Stock: Invitae Plunges 78% on the Brink of Bankruptcy
February 06, 2024
Via
InvestorPlace
Topics
Bankruptcy
Exposures
Financial
Legal
Why Is Invitae (NVTA) Stock Down 75% Today?
February 05, 2024
Via
InvestorPlace
SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy
February 05, 2024
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
12 Health Care Stocks Moving In Monday's Intraday Session
February 05, 2024
Via
Benzinga
Invitae’s High-Stakes Financial Maneuvering: Dilution Might Not Be That Bad
January 23, 2024
Via
Talk Markets
Earnings Preview: Invitae
November 07, 2023
Via
Benzinga
Is Invitae Stock a Buy Now?
November 01, 2023
Via
The Motley Fool
Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle
January 17, 2024
Via
Investor's Business Daily
Topics
Intellectual Property
Exposures
Intellectual Property
US Court Prohibits NeoGenomics To Sell Type Of Diagnostic Kits To Detect Smaller Number Of Cancer Cells, Favoring Natera In Lawsuit
December 28, 2023
Via
Benzinga
Invitae Layoffs 2023: What to Know About the Latest NVTA Job Cuts
December 15, 2023
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Better Growth Stock: CRISPR Therapeutics vs. Invitae
December 05, 2023
Via
The Motley Fool
Invitae (NVTA) Q3 2023 Earnings Call Transcript
November 09, 2023
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 09, 2023
Via
Benzinga
3 Things About Invitae Every Smart Investor Knows
November 04, 2023
Via
The Motley Fool
3 Penny Stocks That Look Like Intriguing Bets for the Long-Term
October 31, 2023
Via
InvestorPlace
Why Invitae Stock Popped Today
October 02, 2023
Via
The Motley Fool
Exposures
Product Safety
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 02, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
